nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Estradiol—osteoporosis	0.0747	0.139	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0747	0.139	CbGbCtD
Oxycodone—CYP3A5—Estradiol—osteoporosis	0.056	0.104	CbGbCtD
Oxycodone—CYP3A4—Estropipate—osteoporosis	0.0526	0.0978	CbGbCtD
Oxycodone—CYP3A4—Calcitriol—osteoporosis	0.0526	0.0978	CbGbCtD
Oxycodone—CYP2D6—Cholecalciferol—osteoporosis	0.0426	0.0792	CbGbCtD
Oxycodone—CYP3A4—Ergocalciferol—osteoporosis	0.0421	0.0782	CbGbCtD
Oxycodone—CYP3A4—Raloxifene—osteoporosis	0.0351	0.0652	CbGbCtD
Oxycodone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0339	0.063	CbGbCtD
Oxycodone—CYP3A4—Cholecalciferol—osteoporosis	0.0271	0.0504	CbGbCtD
Oxycodone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0249	0.0462	CbGbCtD
Oxycodone—CYP3A4—Estradiol—osteoporosis	0.0218	0.0406	CbGbCtD
Oxycodone—Convulsion—Conjugated Estrogens—osteoporosis	0.000252	0.000562	CcSEcCtD
Oxycodone—Dry mouth—Zoledronate—osteoporosis	0.000251	0.000561	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000251	0.00056	CcSEcCtD
Oxycodone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000251	0.00056	CcSEcCtD
Oxycodone—Pruritus—Alendronate—osteoporosis	0.00025	0.000558	CcSEcCtD
Oxycodone—Dyspepsia—Risedronate—osteoporosis	0.00025	0.000557	CcSEcCtD
Oxycodone—Eye disorder—Estradiol—osteoporosis	0.00025	0.000557	CcSEcCtD
Oxycodone—Tinnitus—Estradiol—osteoporosis	0.000249	0.000556	CcSEcCtD
Oxycodone—Constipation—Ethinyl Estradiol—osteoporosis	0.000249	0.000555	CcSEcCtD
Oxycodone—Confusional state—Zoledronate—osteoporosis	0.000248	0.000554	CcSEcCtD
Oxycodone—Hypersensitivity—Calcitriol—osteoporosis	0.000248	0.000554	CcSEcCtD
Oxycodone—Flushing—Estradiol—osteoporosis	0.000248	0.000553	CcSEcCtD
Oxycodone—Cardiac disorder—Estradiol—osteoporosis	0.000248	0.000553	CcSEcCtD
Oxycodone—Myalgia—Conjugated Estrogens—osteoporosis	0.000247	0.000552	CcSEcCtD
Oxycodone—Chest pain—Conjugated Estrogens—osteoporosis	0.000247	0.000552	CcSEcCtD
Oxycodone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000247	0.000552	CcSEcCtD
Oxycodone—Asthenia—Ibandronate—osteoporosis	0.000247	0.000551	CcSEcCtD
Oxycodone—Anxiety—Conjugated Estrogens—osteoporosis	0.000247	0.00055	CcSEcCtD
Oxycodone—Nausea—Etidronic acid—osteoporosis	0.000247	0.00055	CcSEcCtD
Oxycodone—Oedema—Zoledronate—osteoporosis	0.000246	0.000549	CcSEcCtD
Oxycodone—Anaphylactic shock—Zoledronate—osteoporosis	0.000246	0.000549	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000246	0.000548	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000246	0.000548	CcSEcCtD
Oxycodone—Diarrhoea—Estropipate—osteoporosis	0.000246	0.000548	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000245	0.000546	CcSEcCtD
Oxycodone—Infection—Zoledronate—osteoporosis	0.000245	0.000546	CcSEcCtD
Oxycodone—Fatigue—Risedronate—osteoporosis	0.000245	0.000546	CcSEcCtD
Oxycodone—Insomnia—Pamidronate—osteoporosis	0.000244	0.000544	CcSEcCtD
Oxycodone—Pruritus—Ibandronate—osteoporosis	0.000244	0.000543	CcSEcCtD
Oxycodone—Pain—Risedronate—osteoporosis	0.000243	0.000541	CcSEcCtD
Oxycodone—Constipation—Risedronate—osteoporosis	0.000243	0.000541	CcSEcCtD
Oxycodone—Angiopathy—Estradiol—osteoporosis	0.000242	0.000541	CcSEcCtD
Oxycodone—Shock—Zoledronate—osteoporosis	0.000242	0.000541	CcSEcCtD
Oxycodone—Paraesthesia—Pamidronate—osteoporosis	0.000242	0.00054	CcSEcCtD
Oxycodone—Diarrhoea—Alendronate—osteoporosis	0.000242	0.00054	CcSEcCtD
Oxycodone—Asthenia—Calcitriol—osteoporosis	0.000242	0.000539	CcSEcCtD
Oxycodone—Nervous system disorder—Zoledronate—osteoporosis	0.000242	0.000539	CcSEcCtD
Oxycodone—Immune system disorder—Estradiol—osteoporosis	0.000241	0.000538	CcSEcCtD
Oxycodone—Mediastinal disorder—Estradiol—osteoporosis	0.000241	0.000537	CcSEcCtD
Oxycodone—Dyspnoea—Pamidronate—osteoporosis	0.00024	0.000536	CcSEcCtD
Oxycodone—Tachycardia—Zoledronate—osteoporosis	0.00024	0.000536	CcSEcCtD
Oxycodone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00024	0.000535	CcSEcCtD
Oxycodone—Chills—Estradiol—osteoporosis	0.00024	0.000535	CcSEcCtD
Oxycodone—Somnolence—Pamidronate—osteoporosis	0.00024	0.000535	CcSEcCtD
Oxycodone—Skin disorder—Zoledronate—osteoporosis	0.000239	0.000534	CcSEcCtD
Oxycodone—Pruritus—Calcitriol—osteoporosis	0.000238	0.000532	CcSEcCtD
Oxycodone—Hyperhidrosis—Zoledronate—osteoporosis	0.000238	0.000531	CcSEcCtD
Oxycodone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000238	0.000531	CcSEcCtD
Oxycodone—Diarrhoea—Raloxifene—osteoporosis	0.000238	0.000531	CcSEcCtD
Oxycodone—Dyspepsia—Pamidronate—osteoporosis	0.000237	0.000529	CcSEcCtD
Oxycodone—Dizziness—Estropipate—osteoporosis	0.000237	0.000529	CcSEcCtD
Oxycodone—Oedema—Conjugated Estrogens—osteoporosis	0.000237	0.000529	CcSEcCtD
Oxycodone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000237	0.000529	CcSEcCtD
Oxycodone—Infection—Conjugated Estrogens—osteoporosis	0.000236	0.000526	CcSEcCtD
Oxycodone—Diarrhoea—Ibandronate—osteoporosis	0.000236	0.000525	CcSEcCtD
Oxycodone—Anorexia—Zoledronate—osteoporosis	0.000235	0.000524	CcSEcCtD
Oxycodone—Decreased appetite—Pamidronate—osteoporosis	0.000234	0.000523	CcSEcCtD
Oxycodone—Mental disorder—Estradiol—osteoporosis	0.000234	0.000522	CcSEcCtD
Oxycodone—Dizziness—Alendronate—osteoporosis	0.000234	0.000521	CcSEcCtD
Oxycodone—Shock—Conjugated Estrogens—osteoporosis	0.000233	0.00052	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000233	0.000519	CcSEcCtD
Oxycodone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000233	0.000519	CcSEcCtD
Oxycodone—Malnutrition—Estradiol—osteoporosis	0.000233	0.000519	CcSEcCtD
Oxycodone—Fatigue—Pamidronate—osteoporosis	0.000233	0.000519	CcSEcCtD
Oxycodone—Gastrointestinal pain—Risedronate—osteoporosis	0.000232	0.000517	CcSEcCtD
Oxycodone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000232	0.000516	CcSEcCtD
Oxycodone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000231	0.000516	CcSEcCtD
Oxycodone—Pain—Pamidronate—osteoporosis	0.000231	0.000514	CcSEcCtD
Oxycodone—Constipation—Pamidronate—osteoporosis	0.000231	0.000514	CcSEcCtD
Oxycodone—Diarrhoea—Calcitriol—osteoporosis	0.000231	0.000514	CcSEcCtD
Oxycodone—Skin disorder—Conjugated Estrogens—osteoporosis	0.00023	0.000514	CcSEcCtD
Oxycodone—Hypotension—Zoledronate—osteoporosis	0.00023	0.000513	CcSEcCtD
Oxycodone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00023	0.000513	CcSEcCtD
Oxycodone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00023	0.000513	CcSEcCtD
Oxycodone—Dizziness—Raloxifene—osteoporosis	0.00023	0.000513	CcSEcCtD
Oxycodone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000229	0.000511	CcSEcCtD
Oxycodone—Flatulence—Estradiol—osteoporosis	0.000229	0.000511	CcSEcCtD
Oxycodone—Tension—Estradiol—osteoporosis	0.000228	0.000509	CcSEcCtD
Oxycodone—Vomiting—Estropipate—osteoporosis	0.000228	0.000509	CcSEcCtD
Oxycodone—Dysgeusia—Estradiol—osteoporosis	0.000228	0.000508	CcSEcCtD
Oxycodone—Dizziness—Ibandronate—osteoporosis	0.000228	0.000508	CcSEcCtD
Oxycodone—Rash—Estropipate—osteoporosis	0.000226	0.000505	CcSEcCtD
Oxycodone—Dermatitis—Estropipate—osteoporosis	0.000226	0.000504	CcSEcCtD
Oxycodone—Anorexia—Conjugated Estrogens—osteoporosis	0.000226	0.000504	CcSEcCtD
Oxycodone—Nervousness—Estradiol—osteoporosis	0.000226	0.000504	CcSEcCtD
Oxycodone—Urticaria—Risedronate—osteoporosis	0.000225	0.000503	CcSEcCtD
Oxycodone—Back pain—Estradiol—osteoporosis	0.000225	0.000502	CcSEcCtD
Oxycodone—Headache—Estropipate—osteoporosis	0.000225	0.000502	CcSEcCtD
Oxycodone—Vomiting—Alendronate—osteoporosis	0.000225	0.000501	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000224	0.000501	CcSEcCtD
Oxycodone—Abdominal pain—Risedronate—osteoporosis	0.000224	0.0005	CcSEcCtD
Oxycodone—Body temperature increased—Risedronate—osteoporosis	0.000224	0.0005	CcSEcCtD
Oxycodone—Muscle spasms—Estradiol—osteoporosis	0.000224	0.000499	CcSEcCtD
Oxycodone—Rash—Alendronate—osteoporosis	0.000223	0.000497	CcSEcCtD
Oxycodone—Insomnia—Zoledronate—osteoporosis	0.000223	0.000497	CcSEcCtD
Oxycodone—Dermatitis—Alendronate—osteoporosis	0.000223	0.000497	CcSEcCtD
Oxycodone—Feeling abnormal—Pamidronate—osteoporosis	0.000222	0.000496	CcSEcCtD
Oxycodone—Hypotension—Conjugated Estrogens—osteoporosis	0.000222	0.000494	CcSEcCtD
Oxycodone—Headache—Alendronate—osteoporosis	0.000222	0.000494	CcSEcCtD
Oxycodone—Paraesthesia—Zoledronate—osteoporosis	0.000221	0.000493	CcSEcCtD
Oxycodone—Vomiting—Raloxifene—osteoporosis	0.000221	0.000493	CcSEcCtD
Oxycodone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000221	0.000492	CcSEcCtD
Oxycodone—Dyspnoea—Zoledronate—osteoporosis	0.00022	0.00049	CcSEcCtD
Oxycodone—Rash—Raloxifene—osteoporosis	0.000219	0.000489	CcSEcCtD
Oxycodone—Dermatitis—Raloxifene—osteoporosis	0.000219	0.000489	CcSEcCtD
Oxycodone—Somnolence—Zoledronate—osteoporosis	0.000219	0.000488	CcSEcCtD
Oxycodone—Vomiting—Ibandronate—osteoporosis	0.000219	0.000488	CcSEcCtD
Oxycodone—Tremor—Estradiol—osteoporosis	0.000218	0.000486	CcSEcCtD
Oxycodone—Headache—Raloxifene—osteoporosis	0.000218	0.000486	CcSEcCtD
Oxycodone—Rash—Ibandronate—osteoporosis	0.000217	0.000484	CcSEcCtD
Oxycodone—Dermatitis—Ibandronate—osteoporosis	0.000217	0.000484	CcSEcCtD
Oxycodone—Dyspepsia—Zoledronate—osteoporosis	0.000217	0.000484	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000216	0.000482	CcSEcCtD
Oxycodone—Ill-defined disorder—Estradiol—osteoporosis	0.000216	0.000481	CcSEcCtD
Oxycodone—Headache—Ibandronate—osteoporosis	0.000216	0.000481	CcSEcCtD
Oxycodone—Insomnia—Conjugated Estrogens—osteoporosis	0.000215	0.000479	CcSEcCtD
Oxycodone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000214	0.000478	CcSEcCtD
Oxycodone—Vomiting—Calcitriol—osteoporosis	0.000214	0.000478	CcSEcCtD
Oxycodone—Decreased appetite—Zoledronate—osteoporosis	0.000214	0.000478	CcSEcCtD
Oxycodone—Agitation—Estradiol—osteoporosis	0.000214	0.000477	CcSEcCtD
Oxycodone—Nausea—Estropipate—osteoporosis	0.000213	0.000476	CcSEcCtD
Oxycodone—Abdominal pain—Pamidronate—osteoporosis	0.000213	0.000476	CcSEcCtD
Oxycodone—Body temperature increased—Pamidronate—osteoporosis	0.000213	0.000476	CcSEcCtD
Oxycodone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000213	0.000475	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000213	0.000474	CcSEcCtD
Oxycodone—Angioedema—Estradiol—osteoporosis	0.000213	0.000474	CcSEcCtD
Oxycodone—Rash—Calcitriol—osteoporosis	0.000213	0.000474	CcSEcCtD
Oxycodone—Fatigue—Zoledronate—osteoporosis	0.000212	0.000474	CcSEcCtD
Oxycodone—Dermatitis—Calcitriol—osteoporosis	0.000212	0.000473	CcSEcCtD
Oxycodone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000212	0.000472	CcSEcCtD
Oxycodone—Headache—Calcitriol—osteoporosis	0.000211	0.000471	CcSEcCtD
Oxycodone—Somnolence—Conjugated Estrogens—osteoporosis	0.000211	0.00047	CcSEcCtD
Oxycodone—Constipation—Zoledronate—osteoporosis	0.000211	0.00047	CcSEcCtD
Oxycodone—Pain—Zoledronate—osteoporosis	0.000211	0.00047	CcSEcCtD
Oxycodone—Nausea—Alendronate—osteoporosis	0.00021	0.000468	CcSEcCtD
Oxycodone—Malaise—Estradiol—osteoporosis	0.00021	0.000468	CcSEcCtD
Oxycodone—Hypersensitivity—Risedronate—osteoporosis	0.000209	0.000466	CcSEcCtD
Oxycodone—Vertigo—Estradiol—osteoporosis	0.000209	0.000466	CcSEcCtD
Oxycodone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000209	0.000466	CcSEcCtD
Oxycodone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000209	0.000466	CcSEcCtD
Oxycodone—Syncope—Estradiol—osteoporosis	0.000209	0.000465	CcSEcCtD
Oxycodone—Nausea—Raloxifene—osteoporosis	0.000207	0.000461	CcSEcCtD
Oxycodone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000206	0.00046	CcSEcCtD
Oxycodone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000206	0.000459	CcSEcCtD
Oxycodone—Palpitations—Estradiol—osteoporosis	0.000206	0.000458	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000205	0.000457	CcSEcCtD
Oxycodone—Fatigue—Conjugated Estrogens—osteoporosis	0.000205	0.000456	CcSEcCtD
Oxycodone—Nausea—Ibandronate—osteoporosis	0.000205	0.000456	CcSEcCtD
Oxycodone—Loss of consciousness—Estradiol—osteoporosis	0.000204	0.000456	CcSEcCtD
Oxycodone—Asthenia—Risedronate—osteoporosis	0.000204	0.000454	CcSEcCtD
Oxycodone—Feeling abnormal—Zoledronate—osteoporosis	0.000203	0.000453	CcSEcCtD
Oxycodone—Cough—Estradiol—osteoporosis	0.000203	0.000453	CcSEcCtD
Oxycodone—Pain—Conjugated Estrogens—osteoporosis	0.000203	0.000452	CcSEcCtD
Oxycodone—Constipation—Conjugated Estrogens—osteoporosis	0.000203	0.000452	CcSEcCtD
Oxycodone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000201	0.000449	CcSEcCtD
Oxycodone—Pruritus—Risedronate—osteoporosis	0.000201	0.000448	CcSEcCtD
Oxycodone—Nausea—Calcitriol—osteoporosis	0.0002	0.000446	CcSEcCtD
Oxycodone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000199	0.000444	CcSEcCtD
Oxycodone—Hypersensitivity—Pamidronate—osteoporosis	0.000199	0.000443	CcSEcCtD
Oxycodone—Myalgia—Estradiol—osteoporosis	0.000198	0.000442	CcSEcCtD
Oxycodone—Chest pain—Estradiol—osteoporosis	0.000198	0.000442	CcSEcCtD
Oxycodone—Arthralgia—Estradiol—osteoporosis	0.000198	0.000442	CcSEcCtD
Oxycodone—Anxiety—Estradiol—osteoporosis	0.000197	0.00044	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000197	0.000439	CcSEcCtD
Oxycodone—Urticaria—Zoledronate—osteoporosis	0.000196	0.000436	CcSEcCtD
Oxycodone—Discomfort—Estradiol—osteoporosis	0.000196	0.000436	CcSEcCtD
Oxycodone—Abdominal pain—Zoledronate—osteoporosis	0.000195	0.000434	CcSEcCtD
Oxycodone—Body temperature increased—Zoledronate—osteoporosis	0.000195	0.000434	CcSEcCtD
Oxycodone—Diarrhoea—Risedronate—osteoporosis	0.000194	0.000433	CcSEcCtD
Oxycodone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000194	0.000433	CcSEcCtD
Oxycodone—Dry mouth—Estradiol—osteoporosis	0.000194	0.000432	CcSEcCtD
Oxycodone—Asthenia—Pamidronate—osteoporosis	0.000194	0.000432	CcSEcCtD
Oxycodone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000192	0.000429	CcSEcCtD
Oxycodone—Confusional state—Estradiol—osteoporosis	0.000191	0.000427	CcSEcCtD
Oxycodone—Pruritus—Pamidronate—osteoporosis	0.000191	0.000426	CcSEcCtD
Oxycodone—Anaphylactic shock—Estradiol—osteoporosis	0.00019	0.000423	CcSEcCtD
Oxycodone—Oedema—Estradiol—osteoporosis	0.00019	0.000423	CcSEcCtD
Oxycodone—Infection—Estradiol—osteoporosis	0.000189	0.000421	CcSEcCtD
Oxycodone—Urticaria—Conjugated Estrogens—osteoporosis	0.000188	0.00042	CcSEcCtD
Oxycodone—Dizziness—Risedronate—osteoporosis	0.000188	0.000418	CcSEcCtD
Oxycodone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000188	0.000418	CcSEcCtD
Oxycodone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000188	0.000418	CcSEcCtD
Oxycodone—Shock—Estradiol—osteoporosis	0.000187	0.000417	CcSEcCtD
Oxycodone—Nervous system disorder—Estradiol—osteoporosis	0.000186	0.000415	CcSEcCtD
Oxycodone—Tachycardia—Estradiol—osteoporosis	0.000185	0.000413	CcSEcCtD
Oxycodone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000185	0.000413	CcSEcCtD
Oxycodone—Diarrhoea—Pamidronate—osteoporosis	0.000185	0.000412	CcSEcCtD
Oxycodone—Skin disorder—Estradiol—osteoporosis	0.000184	0.000411	CcSEcCtD
Oxycodone—Hyperhidrosis—Estradiol—osteoporosis	0.000184	0.000409	CcSEcCtD
Oxycodone—Rash—Ethinyl Estradiol—osteoporosis	0.000183	0.000409	CcSEcCtD
Oxycodone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000183	0.000409	CcSEcCtD
Oxycodone—Headache—Ethinyl Estradiol—osteoporosis	0.000182	0.000407	CcSEcCtD
Oxycodone—Hypersensitivity—Zoledronate—osteoporosis	0.000182	0.000405	CcSEcCtD
Oxycodone—Vomiting—Risedronate—osteoporosis	0.00018	0.000402	CcSEcCtD
Oxycodone—Rash—Risedronate—osteoporosis	0.000179	0.000399	CcSEcCtD
Oxycodone—Dermatitis—Risedronate—osteoporosis	0.000179	0.000399	CcSEcCtD
Oxycodone—Dizziness—Pamidronate—osteoporosis	0.000178	0.000398	CcSEcCtD
Oxycodone—Headache—Risedronate—osteoporosis	0.000178	0.000396	CcSEcCtD
Oxycodone—Asthenia—Zoledronate—osteoporosis	0.000177	0.000394	CcSEcCtD
Oxycodone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000175	0.00039	CcSEcCtD
Oxycodone—Pruritus—Zoledronate—osteoporosis	0.000174	0.000389	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000173	0.000386	CcSEcCtD
Oxycodone—Nausea—Ethinyl Estradiol—osteoporosis	0.000173	0.000385	CcSEcCtD
Oxycodone—Insomnia—Estradiol—osteoporosis	0.000172	0.000383	CcSEcCtD
Oxycodone—Vomiting—Pamidronate—osteoporosis	0.000171	0.000382	CcSEcCtD
Oxycodone—Paraesthesia—Estradiol—osteoporosis	0.00017	0.00038	CcSEcCtD
Oxycodone—Asthenia—Conjugated Estrogens—osteoporosis	0.00017	0.00038	CcSEcCtD
Oxycodone—Rash—Pamidronate—osteoporosis	0.00017	0.000379	CcSEcCtD
Oxycodone—Dermatitis—Pamidronate—osteoporosis	0.00017	0.000379	CcSEcCtD
Oxycodone—Dyspnoea—Estradiol—osteoporosis	0.000169	0.000377	CcSEcCtD
Oxycodone—Headache—Pamidronate—osteoporosis	0.000169	0.000377	CcSEcCtD
Oxycodone—Somnolence—Estradiol—osteoporosis	0.000169	0.000376	CcSEcCtD
Oxycodone—Diarrhoea—Zoledronate—osteoporosis	0.000169	0.000376	CcSEcCtD
Oxycodone—Nausea—Risedronate—osteoporosis	0.000169	0.000376	CcSEcCtD
Oxycodone—Pruritus—Conjugated Estrogens—osteoporosis	0.000168	0.000374	CcSEcCtD
Oxycodone—Dyspepsia—Estradiol—osteoporosis	0.000167	0.000373	CcSEcCtD
Oxycodone—Decreased appetite—Estradiol—osteoporosis	0.000165	0.000368	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000164	0.000366	CcSEcCtD
Oxycodone—Fatigue—Estradiol—osteoporosis	0.000164	0.000365	CcSEcCtD
Oxycodone—Dizziness—Zoledronate—osteoporosis	0.000163	0.000363	CcSEcCtD
Oxycodone—Constipation—Estradiol—osteoporosis	0.000162	0.000362	CcSEcCtD
Oxycodone—Pain—Estradiol—osteoporosis	0.000162	0.000362	CcSEcCtD
Oxycodone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000162	0.000362	CcSEcCtD
Oxycodone—Nausea—Pamidronate—osteoporosis	0.00016	0.000357	CcSEcCtD
Oxycodone—Dizziness—Conjugated Estrogens—osteoporosis	0.000157	0.00035	CcSEcCtD
Oxycodone—Vomiting—Zoledronate—osteoporosis	0.000157	0.000349	CcSEcCtD
Oxycodone—Feeling abnormal—Estradiol—osteoporosis	0.000156	0.000349	CcSEcCtD
Oxycodone—Rash—Zoledronate—osteoporosis	0.000155	0.000346	CcSEcCtD
Oxycodone—Gastrointestinal pain—Estradiol—osteoporosis	0.000155	0.000346	CcSEcCtD
Oxycodone—Dermatitis—Zoledronate—osteoporosis	0.000155	0.000346	CcSEcCtD
Oxycodone—Headache—Zoledronate—osteoporosis	0.000154	0.000344	CcSEcCtD
Oxycodone—Vomiting—Conjugated Estrogens—osteoporosis	0.000151	0.000336	CcSEcCtD
Oxycodone—Urticaria—Estradiol—osteoporosis	0.000151	0.000336	CcSEcCtD
Oxycodone—Abdominal pain—Estradiol—osteoporosis	0.00015	0.000335	CcSEcCtD
Oxycodone—Body temperature increased—Estradiol—osteoporosis	0.00015	0.000335	CcSEcCtD
Oxycodone—Rash—Conjugated Estrogens—osteoporosis	0.00015	0.000334	CcSEcCtD
Oxycodone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000149	0.000333	CcSEcCtD
Oxycodone—Headache—Conjugated Estrogens—osteoporosis	0.000149	0.000331	CcSEcCtD
Oxycodone—Nausea—Zoledronate—osteoporosis	0.000146	0.000326	CcSEcCtD
Oxycodone—Nausea—Conjugated Estrogens—osteoporosis	0.000141	0.000314	CcSEcCtD
Oxycodone—Hypersensitivity—Estradiol—osteoporosis	0.00014	0.000312	CcSEcCtD
Oxycodone—Asthenia—Estradiol—osteoporosis	0.000136	0.000304	CcSEcCtD
Oxycodone—Pruritus—Estradiol—osteoporosis	0.000134	0.0003	CcSEcCtD
Oxycodone—Diarrhoea—Estradiol—osteoporosis	0.00013	0.00029	CcSEcCtD
Oxycodone—Dizziness—Estradiol—osteoporosis	0.000126	0.00028	CcSEcCtD
Oxycodone—Vomiting—Estradiol—osteoporosis	0.000121	0.000269	CcSEcCtD
Oxycodone—Rash—Estradiol—osteoporosis	0.00012	0.000267	CcSEcCtD
Oxycodone—Dermatitis—Estradiol—osteoporosis	0.00012	0.000267	CcSEcCtD
Oxycodone—Headache—Estradiol—osteoporosis	0.000119	0.000265	CcSEcCtD
Oxycodone—Nausea—Estradiol—osteoporosis	0.000113	0.000252	CcSEcCtD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.25e-05	0.00242	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PTH—osteoporosis	3.22e-05	0.00241	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—FDPS—osteoporosis	3.17e-05	0.00236	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PKM—osteoporosis	3.17e-05	0.00236	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CNR2—osteoporosis	3.14e-05	0.00234	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SOST—osteoporosis	3.08e-05	0.0023	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—WNT1—osteoporosis	3.06e-05	0.00228	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PTHLH—osteoporosis	3.05e-05	0.00227	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	3.04e-05	0.00227	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPD2—osteoporosis	3e-05	0.00224	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PGLS—osteoporosis	3e-05	0.00224	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MGLL—osteoporosis	2.98e-05	0.00223	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTH—osteoporosis	2.93e-05	0.00218	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LRP5—osteoporosis	2.91e-05	0.00217	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.87e-05	0.00214	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.86e-05	0.00213	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CNR2—osteoporosis	2.85e-05	0.00213	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	2.85e-05	0.00212	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.83e-05	0.00211	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LRP6—osteoporosis	2.79e-05	0.00208	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTH1R—osteoporosis	2.78e-05	0.00208	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALCR—osteoporosis	2.78e-05	0.00208	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PTHLH—osteoporosis	2.77e-05	0.00206	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PNP—osteoporosis	2.74e-05	0.00205	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ATIC—osteoporosis	2.74e-05	0.00205	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PTH—osteoporosis	2.73e-05	0.00203	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—WNT1—osteoporosis	2.68e-05	0.002	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CALCA—osteoporosis	2.68e-05	0.002	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PTHLH—osteoporosis	2.67e-05	0.00199	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	2.66e-05	0.00198	CbGpPWpGaD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.62e-05	0.00195	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MGLL—osteoporosis	2.62e-05	0.00195	CbGpPWpGaD
Oxycodone—Naloxone—ESR1—osteoporosis	2.59e-05	1	CrCbGaD
Oxycodone—OPRK1—Signaling Pathways—LRP5—osteoporosis	2.55e-05	0.00191	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—POMC—osteoporosis	2.48e-05	0.00185	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTH—osteoporosis	2.47e-05	0.00185	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LRP6—osteoporosis	2.44e-05	0.00182	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CALCA—osteoporosis	2.44e-05	0.00182	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTHLH—osteoporosis	2.43e-05	0.00181	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—POMC—osteoporosis	2.43e-05	0.00181	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.42e-05	0.0018	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CNR2—osteoporosis	2.41e-05	0.0018	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CALCA—osteoporosis	2.35e-05	0.00176	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TLN1—osteoporosis	2.35e-05	0.00175	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CA2—osteoporosis	2.33e-05	0.00174	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—OXCT1—osteoporosis	2.33e-05	0.00174	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—FDPS—osteoporosis	2.29e-05	0.00171	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PKM—osteoporosis	2.29e-05	0.00171	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MGLL—osteoporosis	2.27e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—WNT1—osteoporosis	2.27e-05	0.00169	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	2.26e-05	0.00168	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MGLL—osteoporosis	2.21e-05	0.00165	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—POMC—osteoporosis	2.18e-05	0.00162	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPD2—osteoporosis	2.17e-05	0.00162	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PGLS—osteoporosis	2.17e-05	0.00162	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LRP5—osteoporosis	2.16e-05	0.00161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CALCA—osteoporosis	2.14e-05	0.00159	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.12e-05	0.00158	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LRP6—osteoporosis	2.06e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TLN1—osteoporosis	2.06e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	2.05e-05	0.00153	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—P4HB—osteoporosis	2.03e-05	0.00151	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	1.99e-05	0.00148	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ATIC—osteoporosis	1.98e-05	0.00148	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PNP—osteoporosis	1.98e-05	0.00148	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTH—osteoporosis	1.97e-05	0.00147	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAP1A—osteoporosis	1.94e-05	0.00145	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—IDH2—osteoporosis	1.93e-05	0.00144	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CNR2—osteoporosis	1.92e-05	0.00143	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—ADCY5—osteoporosis	1.91e-05	0.00142	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFATC1—osteoporosis	1.89e-05	0.00141	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.88e-05	0.0014	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DKK1—osteoporosis	1.88e-05	0.0014	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.85e-05	0.00138	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—POMC—osteoporosis	1.84e-05	0.00137	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP27A1—osteoporosis	1.82e-05	0.00136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—WNT1—osteoporosis	1.81e-05	0.00135	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CALCA—osteoporosis	1.81e-05	0.00135	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—P4HB—osteoporosis	1.78e-05	0.00133	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ACP5—osteoporosis	1.77e-05	0.00132	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGA—osteoporosis	1.76e-05	0.00131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TLN1—osteoporosis	1.74e-05	0.0013	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ADCY5—osteoporosis	1.73e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTH—osteoporosis	1.73e-05	0.00129	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—POMC—osteoporosis	1.73e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAP1A—osteoporosis	1.7e-05	0.00127	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—OXCT1—osteoporosis	1.69e-05	0.00126	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CA2—osteoporosis	1.69e-05	0.00126	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CNR2—osteoporosis	1.69e-05	0.00126	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	1.67e-05	0.00125	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFATC1—osteoporosis	1.66e-05	0.00124	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DKK1—osteoporosis	1.65e-05	0.00123	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TPI1—osteoporosis	1.64e-05	0.00123	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MGLL—osteoporosis	1.64e-05	0.00123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTHLH—osteoporosis	1.63e-05	0.00122	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BMP2—osteoporosis	1.63e-05	0.00122	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PKM—osteoporosis	1.63e-05	0.00121	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—FDPS—osteoporosis	1.63e-05	0.00121	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGB—osteoporosis	1.6e-05	0.00119	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—WNT1—osteoporosis	1.59e-05	0.00118	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—P4HB—osteoporosis	1.55e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PSMA5—osteoporosis	1.54e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PSMA2—osteoporosis	1.54e-05	0.00115	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPD2—osteoporosis	1.54e-05	0.00115	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PGLS—osteoporosis	1.54e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGA—osteoporosis	1.54e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	1.52e-05	0.00113	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GAPDH—osteoporosis	1.52e-05	0.00113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—P4HB—osteoporosis	1.5e-05	0.00112	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RAP1A—osteoporosis	1.48e-05	0.0011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTH—osteoporosis	1.46e-05	0.00109	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CALCA—osteoporosis	1.44e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAP1A—osteoporosis	1.44e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BMP2—osteoporosis	1.43e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTHLH—osteoporosis	1.43e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CNR2—osteoporosis	1.42e-05	0.00106	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	1.41e-05	0.00106	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ATIC—osteoporosis	1.41e-05	0.00105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PNP—osteoporosis	1.41e-05	0.00105	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—POMC—osteoporosis	1.4e-05	0.00105	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGB—osteoporosis	1.4e-05	0.00105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFATC1—osteoporosis	1.4e-05	0.00105	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—IDH2—osteoporosis	1.4e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DKK1—osteoporosis	1.39e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PSMA2—osteoporosis	1.35e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PSMA5—osteoporosis	1.35e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—WNT1—osteoporosis	1.34e-05	0.000999	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.31e-05	0.00098	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KL—osteoporosis	1.31e-05	0.000975	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGA—osteoporosis	1.3e-05	0.000972	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	1.28e-05	0.000958	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ACP5—osteoporosis	1.28e-05	0.000954	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—POMC—osteoporosis	1.27e-05	0.000951	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CALCA—osteoporosis	1.26e-05	0.000942	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6R—osteoporosis	1.24e-05	0.000928	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—POMC—osteoporosis	1.23e-05	0.000918	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTHLH—osteoporosis	1.21e-05	0.000904	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BMP2—osteoporosis	1.21e-05	0.000904	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CA2—osteoporosis	1.2e-05	0.000895	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—OXCT1—osteoporosis	1.2e-05	0.000895	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ENO1—osteoporosis	1.19e-05	0.000891	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TPI1—osteoporosis	1.19e-05	0.000887	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGB—osteoporosis	1.19e-05	0.000885	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000878	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000878	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MGLL—osteoporosis	1.17e-05	0.000872	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KL—osteoporosis	1.15e-05	0.000855	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PSMA5—osteoporosis	1.14e-05	0.000854	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PSMA2—osteoporosis	1.14e-05	0.000854	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—POMC—osteoporosis	1.13e-05	0.000841	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.12e-05	0.000834	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—P4HB—osteoporosis	1.12e-05	0.000834	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GAPDH—osteoporosis	1.1e-05	0.000818	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.09e-05	0.000813	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RAP1A—osteoporosis	1.07e-05	0.000797	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.07e-05	0.000796	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PKM—osteoporosis	1.06e-05	0.000794	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—FDPS—osteoporosis	1.06e-05	0.000794	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.04e-05	0.000776	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.02e-05	0.000764	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PGLS—osteoporosis	1.01e-05	0.000752	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPD2—osteoporosis	1.01e-05	0.000752	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—IDH2—osteoporosis	9.94e-06	0.000742	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPP1—osteoporosis	9.9e-06	0.000739	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KL—osteoporosis	9.69e-06	0.000723	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP19A1—osteoporosis	9.55e-06	0.000713	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—POMC—osteoporosis	9.45e-06	0.000705	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP27A1—osteoporosis	9.35e-06	0.000697	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ATIC—osteoporosis	9.22e-06	0.000688	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PNP—osteoporosis	9.22e-06	0.000688	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6R—osteoporosis	9.21e-06	0.000687	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ACP5—osteoporosis	9.09e-06	0.000678	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADCY5—osteoporosis	8.98e-06	0.00067	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS2—osteoporosis	8.96e-06	0.000668	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LEP—osteoporosis	8.77e-06	0.000654	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPP1—osteoporosis	8.68e-06	0.000648	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ENO1—osteoporosis	8.64e-06	0.000644	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSMA2—osteoporosis	8.51e-06	0.000635	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSMA5—osteoporosis	8.51e-06	0.000635	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TPI1—osteoporosis	8.45e-06	0.000631	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—osteoporosis	8.37e-06	0.000624	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—P4HB—osteoporosis	7.95e-06	0.000593	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS2—osteoporosis	7.85e-06	0.000586	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA2—osteoporosis	7.84e-06	0.000585	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—OXCT1—osteoporosis	7.84e-06	0.000585	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS1—osteoporosis	7.82e-06	0.000583	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADCY5—osteoporosis	7.8e-06	0.000582	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GAPDH—osteoporosis	7.8e-06	0.000582	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX1—osteoporosis	7.78e-06	0.00058	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—osteoporosis	7.69e-06	0.000573	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MGLL—osteoporosis	7.64e-06	0.00057	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RAP1A—osteoporosis	7.6e-06	0.000567	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADCY5—osteoporosis	7.59e-06	0.000566	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—POMC—osteoporosis	7.53e-06	0.000562	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6R—osteoporosis	7.35e-06	0.000548	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—osteoporosis	7.34e-06	0.000548	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—osteoporosis	7.34e-06	0.000547	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—osteoporosis	7.24e-06	0.00054	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—osteoporosis	7.18e-06	0.000535	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP19A1—osteoporosis	6.9e-06	0.000515	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS1—osteoporosis	6.86e-06	0.000512	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS2—osteoporosis	6.64e-06	0.000495	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—osteoporosis	6.6e-06	0.000493	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH2—osteoporosis	6.5e-06	0.000485	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—osteoporosis	6.5e-06	0.000485	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6R—osteoporosis	6.44e-06	0.000481	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—osteoporosis	6.35e-06	0.000474	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—osteoporosis	6.2e-06	0.000463	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO1—osteoporosis	6.14e-06	0.000458	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.11e-06	0.000456	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMA2—osteoporosis	6.05e-06	0.000451	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMA5—osteoporosis	6.05e-06	0.000451	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ACP5—osteoporosis	5.94e-06	0.000443	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS1—osteoporosis	5.79e-06	0.000432	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—osteoporosis	5.74e-06	0.000428	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADCY5—osteoporosis	5.64e-06	0.000421	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—osteoporosis	5.62e-06	0.000419	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—osteoporosis	5.58e-06	0.000416	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—osteoporosis	5.54e-06	0.000413	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TPI1—osteoporosis	5.53e-06	0.000412	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6R—osteoporosis	5.44e-06	0.000406	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—osteoporosis	5.37e-06	0.0004	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—P4HB—osteoporosis	5.2e-06	0.000388	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—osteoporosis	5.19e-06	0.000387	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GAPDH—osteoporosis	5.1e-06	0.00038	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RAP1A—osteoporosis	4.97e-06	0.000371	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.91e-06	0.000366	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—osteoporosis	4.86e-06	0.000362	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—osteoporosis	4.35e-06	0.000325	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—osteoporosis	4.34e-06	0.000324	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—osteoporosis	4.15e-06	0.00031	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—osteoporosis	4.1e-06	0.000306	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO1—osteoporosis	4.01e-06	0.0003	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADCY5—osteoporosis	4.01e-06	0.000299	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—osteoporosis	4e-06	0.000298	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMA5—osteoporosis	3.96e-06	0.000295	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMA2—osteoporosis	3.96e-06	0.000295	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—osteoporosis	3.82e-06	0.000285	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—osteoporosis	3.81e-06	0.000284	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—osteoporosis	3.69e-06	0.000275	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—osteoporosis	3.27e-06	0.000244	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—osteoporosis	3.23e-06	0.000241	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—osteoporosis	3.22e-06	0.00024	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.21e-06	0.000239	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—osteoporosis	2.95e-06	0.00022	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—osteoporosis	2.87e-06	0.000214	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADCY5—osteoporosis	2.62e-06	0.000196	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—osteoporosis	2.61e-06	0.000195	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—osteoporosis	2.42e-06	0.000181	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—osteoporosis	2.41e-06	0.00018	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—osteoporosis	1.93e-06	0.000144	CbGpPWpGaD
